UK markets open in 4 hours 23 minutes
NIKKEI 225
39,705.30 +363.76 (+0.92%) HANG SENG
17,838.16 +121.69 (+0.69%) CRUDE OIL
82.18 +0.44 (+0.54%) GOLD FUTURES
2,332.80 -3.80 (-0.16%) DOW
39,164.06 +36.26 (+0.09%) Bitcoin GBP
48,791.79 +555.27 (+1.15%)
Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.11 |
| Open | 13.18 |
| Bid | 12.75 x 600 |
| Ask | 12.89 x 1900 |
| Day's range | 12.77 - 13.30 |
| 52-week range | 3.53 - 23.86 |
| Volume | |
| Avg. volume | 15,845,091 |
| Market cap | 1.931B |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 22.80 |
Investor's Business DailyThe FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock has pulled back after hitting a nearly two-year high earlier this month. Is NVAX stock a buy right now?
GuruFocus.comInsider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 61,760 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
© 2024 Yahoo. All rights reserved.